Hypersplenism is the most common
splenic disease and usually refers to a clinical
syndrome of increased splenic size and/or
cytopenia due to various causes.
Hypersplenism is most often
secondary to cirrhotic
hypertension.
Liver transplantation can effectively relieve
hypersplenism in
patients with
liver cirrhosis, but there are also some
patients with persistent
hypersplenism after
liver transplantation or
recurrence after remission. Other
treatment modalities for postoperative intractable
hypersplenism include
splenectomy and partial
splenic artery embolization. This article reviews the
research progress of
hypersplenism after
liver transplantation for
liver cirrhosis with
hypersplenism.